Social Neuroscience and Psychotherapy Lab
SNAP Lab aims to maximize the benefits of therapeutic alliance and psychotherapy through the adjunct use of social psychopharmacology, such as oxytocin, MDMA, and psilocybin.
Chris Stauffer, MD |
Dr. Stauffer (he/they) is Associate Professor of Psychiatry at Oregon Health & Science University (OHSU) and dual board-certified in Psychiatry and Addiction Medicine. Dr. Stauffer is an OHSU medical school alum and completed Adult Psychiatry Residency and an Advanced Neuroscience Research Fellowship at the University of California, San Francisco (UCSF). Dr. Stauffer's previous clinical trial work includes Phase 2 (NCT03282123) and Phase 3 (NCT03537014) trials of MDMA-assisted psychotherapy for PTSD, a study of psilocybin-assisted group therapy for demoralization in long-term AIDS survivors (NCT02950467), and several studies of intranasal oxytocin as an intervention for substance use disorders--including a study of oxytocin-enhanced group therapy for methamphetamine-using men who have sex with men (NCT02881177). Dr. Stauffer serves as Supervisor and Assistant Trainer for MAPS’ MDMA Therapy Training Program, is a member of the Oregon Governor's Psilocybin Advisory Board, is Co-Chair of the Fireside Project's Equity & Liberation Research Committee, and has served in curriculum development, teaching, and mentorship roles for the Center for Psychedelic Therapies and Research at CIIS, Integrative Psychiatry Institute’s Psychedelic-Assisted Therapy Training, Psychedelic.Support, Polaris Insight Center, SoundMind Institute, and Alma Institute.
Alissa Bazinet, Phd |
Dr. Bazinet (she/her) is a licensed clinical psychologist with a professional background in both research and provision of clinical services. She received her PhD in 2013 from the University of California, San Diego & San Diego State University’s joint doctoral program in clinical psychology and completed a clinical internship and research postdoc at OHSU. She is a co-founder and the Director of Research and Development at Sequoia Center, a community nonprofit clinic offering sliding-scale ketamine-assisted psychotherapy and related services, with a focus on equitable access for members of historically marginalized populations. Dr. Bazinet’s previous research focused on understanding substance use and addiction through the lens of psychoneuroimmunology, as well as evaluating psychotherapeutic and biomedical interventions to aid in recovery from prolonged substance use. Her current research interests center on developing best practices and standards of care for the delivery of psychedelic-assisted therapies within medical and non-medical contexts. Dr. Bazinet serves on the board of the National Psychedelics Association and on the training subcommittee of the Oregon Psilocybin Advisory Board. She is a longtime lead volunteer with the Zendo Project and other organizations that provide crisis response, peer support and harm reduction services at music festivals and events.
Kevin Rothstein |
Kevin (he/him) has a background in science education and administration. He received his BS in Biology from Georgia Tech and MS in Ecology and Evolutionary Biology from UC Irvine. Through his experience as a teaching assistant and middle/high school teacher, and then later as an assistant principal and administrative coordinator, he has enjoyed the opportunity to connect with and support the people around him. Connections around the struggles of people from all aspects of his life have encouraged him to pursue opportunities in clinical trauma work. His goal is to continue education to explore the relationship between trauma and mental illness. He is particularly interested in how psychedelic-assisted psychotherapy can help people work through traumatic experiences and associated trauma and mental illness.
Angelica Spata |
Angelica (she/her) received her BA in Psychology from Cal Poly Pomona. She has been working as a research assistant since 2020, with a focus in psychedelics, psychological flexibility, and substance use. She was drawn to the field through her volunteer experiences as a harm reduction medic at various music and arts festivals where she observed a need for compassionate, trauma-informed psychiatric care. Angelica’s aim is to holistically approach mental health treatments and is interested in psychedelic-assisted therapy for management of addiction and co-occurring disorders. She plans on pursuing a career as a Psychiatric Mental Health Nurse Practitioner.
tyler king |
Tyler (he/him) is an undergraduate at Portland State University set to graduate with Honors in the Fall of 2023 with his BA in Psychology and a minor in creative writing. Tyler plans to continue his education as a graduate student with a focus in Clinical Psychology and eventually earn his PhD. At the start of the pandemic, Tyler decided to leave his job as an in-home personal trainer to go back to school and pursue a career in mental health and trauma recovery. After realizing many of his training sessions were becoming therapy sessions for his clients, he discovered he was more interested in supporting his clients emotionally rather than writing workouts for them. Tyler is interested in the potential of psychedelics as psychotherapeutic tools and is excited to be on a research team working to explore this area. Tyler's interests include writing short stories and poetry, working out, knitting, and spending weekends on the couch watching movies with his fiancé, Eric, and their small, grumpy poodle named Jake.
Neeka Levy |
Neeka (she/her) is a first generation Ukrainian-American who received her BS in Neuroscience and Nursing from the University of Pittsburgh. She works as a psychiatric nurse on an acute inpatient psychiatric unit. Throughout her undergraduate career, she volunteered in psychiatric and neuroscience labs. As a result of her life experience, she grew a passion for the mental health field. She became dedicated to help others in bridging access to high quality psychiatric services. Her holistic cultural background pushed her into exploring various non-traditional psychiatric treatments, including psychedelics. She is continuing on her education in a Psychiatric Mental Health Nurse Practitioner program at Johns Hopkins University. She and her dog enjoy traveling, rock climbing, hiking, backpacking, spelunking, split boarding, photography and painting.
libby alfieri |
Libby (any pronouns) is an undergraduate student at Reed College pursuing a degree in Psychology with a concentration in Cognitive Science. They have always looked to nature to answer their questions, both philosophical and scientific, fostering a longtime interest in plants as medicinal and/or therapeutic interventions. Long-term, they hope to explore the integration of nature, music, and art into psychedelic interventions. Besides a fascination and respect for the Earth and what it has to offer, personal experiences have led Libby to be especially focused on harm reduction, as well as equitable, culturally competent, and accessible healthcare.
River Jenkins |
River (she/her) received her B.S. in Psychology from Oregon State University. She is deeply interested in consciousness studies, the psychopharmacological investigation of psychedelic substances, and equity and inclusion in psychedelic research. She works in harm reduction as a support line supervisor for Fireside Project’s psychedelic support line and she is a licensed Oregon psilocybin facilitator. When she isn’t in the lab you can find her building her off-grid permaculture community in the high desert, kayaking, or exploring the forests and coastlines of the Pacific Northwest with her partner and their three dogs.
Alyssa Gursky, MA |
Alyssa (they/she) is a Licensed Professional Counselor in the state of Oregon. They received her Master’s Degree in Clinical Mental Health Counseling, concentrating in Transpersonal Art Therapy from Naropa University. Post-graduate, Alyssa has completed part A-D of the MDMA-Assisted Psychotherapy training with MAPS and has completed multiple Ketamine Therapy Trainings with The Ketamine Training Center and Polaris Insight Center. They own and operate Psychedelic Art Therapy, a small private practice offering somatic psychotherapy, art therapy, psychedelic integration, and ketamine-assisted therapy. Additionally, Alyssa works at Sequoia Center, a non-profit creating accessibility for ketamine assisted psychotherapy. Alyssa also mentors at Alma Institute, a Psilocybin training program in Oregon. In all aspects of their professional life, they prioritize accessibility and affordability, primarily to the LGBTQIA+ community. Outside of their busy professional life, they’re a mixed media/collage artist and an avid reader, often reading 3 books at once.
Diana Quinn, ND |
Diana (she/they) is a licensed naturopathic doctor with a focus on integrative mental health, psychoneuroimmunology, and healing justice. As a queer Chicana, her work has centered care of marginalized communities, including people of color and the 2SLGBTQIA+ community, for over 20 years. Dr. Quinn is the Assistant Director of Community Care in the Naropa Center for Psychedelic Studies. In the emerging field of psychedelic medicine, she works to ensure ethical, safe, and inclusive care, as well as anti-oppressive approaches in training facilitators in both the medical and adult-use models. She serves on multiple advisory boards and working groups dedicated to building ethical integrity, equity, accessibility, reciprocity, and cultural humility in psychedelic medicine.
Rebecca Morris,BCC-MH |
Chaplain Morris (she/ X ) is a Board Certified Mental Health Specialty Chaplain who works primarily in a mental health outpatient setting. Rebecca is trained in MDMA-assisted therapy and is an ordained Buddhist, whose teachings are inspired by numerous indigenous and nature-based traditions. Her unique perspective equips her to cultivate mythic and archetypal transformation, and ceremonial initiations and rites of passage. Uniting these diverse understandings, her model of celebratory healing and soul-centered embodiment fosters compassion in individuals as they become comfortable in the mystery and paradox of life to embrace suffering. Rebecca is the granddaughter of a WWII infantry Veteran and was raised by Vietnam Veterans. She has experienced the interpersonal impact of combat trauma, PTSD, and moral injury, and is committed to preventive ethics—breaking the cycle of shame, violent communication, and hurtful actions that continue to impact individuals, families, and communities. Her vision is to help individuals discover their compassionate hearts and find ways to embody their own personal versions of kindness from the inside out.
Marx Cassity, RN, LMFT |
Marx Cassity's (they/them) journey as a therapist began by overcoming their own trauma and developing resilience and empowerment as a two spirit, queer, mixed-race Native American who grew up on the Osage reservation of Oklahoma as an enrolled member of the tribe. They are trained in MDMA-assisted psychotherapy for PTSD and sit on the advisory council on diversity for the Multidisciplinary Association of Psychedelic Studies (MAPS). Before becoming a psychotherapist, they completed a Bachelor of Science in Nursing at the University of Oklahoma, and have been a Registered Nurse for 26 years, with specializations in ICU, emergency room, and home health nursing. They hold a Master of Arts in Counseling Psychology from John F. Kennedy University in Berkeley, California, and are a Licensed Marriage and Family Therapist in the state of California (LMFT #92335) and the state of Oregon (LMFT #T1416). They completed training in Eye Movement Desensitization and Reprocessing (EMDR) at the Native American Health Center of San Francisco, and training in Trauma-Focused Cognitive Behavioral Therapy at the Indian Country Child Trauma Center at the University of Oklahoma.
Karin Gagnon |
Karin Gagnon (she/her) is a Grof-Certified Holotropic Breathwork Facilitator with over 35 years of experience facilitating workshops internationally. She has completed certification for the MAPS MDMA Therapy Program and now facilitates experiential breathwork workshops with new MDMA Therapist trainees. Karin is part of the American Psychedelic Practitioners Association (APPA) Advisory Council and serves as Advisor and Mentor for a number of other non-profit organizations in her community.
Donny Reed |
Donny Reed (he/him) is a combat Veteran and someone who has lived with the struggles of PTSD and moral injury. Over the past four years, he has volunteered as a co-facilitator for several outpatient mental health groups. As a certified Peer Specialist, he has honed the ability to create authentic safe spaces for clients with PTSD, assists them with establishing trust and rapport with mental health practitioners, and has cultivated many meditation techniques and grounding strategies that he shares with clients on their healing journeys. In 2020, Donny completed the MAPS MDMA Therapy Training Program and currently works as a psychedelic facilitator with the SNaP Lab.
Zach Skiles, Psyd |
Zach Skiles (he/him) is a United States Marine Corps Veteran who has navigated combat operations and PTSD, which ultimately led to a transformative journey as a therapist helping Veterans within his community. When helping start the first PTSD clinic in South Sudan for Veterans and family members of the Sudanese People’s Liberation Army, Zach developed an interest in community-based care & traditional healing modalities. Starting in the U.S. as a Peer Counselor for Iraq and Afghanistan Veterans, he trained as a clinical psychologist, while also facilitating psychedelic-assisted therapies for individuals & groups of U.S. Special Forces communities at The Mission Within in Mexico. In addition to his work in the SNaP Lab, Zach also serves as educator with the Center of the Science of Psychedelics at UC Berkeley.
Jenna Kachmarik | Phd candidate
Jenna (she/her) is honored and excited to be part of OHSU’s Clinical Psychology Ph.D. program under the mentorship of Dr. Chris Stauffer and Dr. Jennifer Loftis. Previously, she was a volunteer research associate in a biobehavioral research lab exploring the bidirectional relationship between mental and physical health in the context of stress. Additionally, several years of working in pharmacy has granted her insight into the benefits and pitfalls of a medical model primarily focused on symptom management. Together her research, work, and personal healing experiences have oriented her interests toward the field of health psychology as well as addressing and healing root causes for both mental and physical conditions. Jenna is interested in the power of psychedelic experiences to help participants unlock their own capacity for physical and emotional healing; she aspires to become a practitioner of psychedelic-assisted psychotherapy. She is deeply curious about the potential for psychedelics to improve chronic health conditions (e.g., autoimmune disorders) and potential mechanisms therein. As a graduate student, she will have the unique opportunity to combine her dual passions for health psychology and psychedelic research/therapy by investigating outcomes of psychedelic-assisted psychotherapy from a psychoneuroimmunological lens.
Ayanna Bell |
Ayanna (she/her) is a current Clinical Psychology PhD student under the mentorship of Dr. Kathleen Carlson, Dr. Jeni Johnstone, and Dr. Chris Stauffer. She was born in Hawai’i and raised in Georgia. She earned her B.S. in Neuroscience with a minor in Artificial Intelligence at Agnes Scott College. There she was an undergraduate research assistant in numerous labs exploring novel methods to treat neurological diseases and psychiatric disorders. Her research interests include providing culturally competent care to those seeking psychiatric treatment, sociobehavioral impacts on human health, innovative initiatives for health, mindfulness and meditation, the utilization of micronutrients to treat symptoms related to psychiatric disorders, and exploring psychedelic-assisted psychotherapy.
Philip Bouleh |
Philip (he/him) is currently a Clinical Psychology PhD student at OHSU under the mentorship of Dr. Chris Stauffer. He was born in Amman, Jordan and grew up in Lebanon before immigrating to the United States in 2004 with his family. He graduated in 2020 from Portland State University with a B.S. in philosophy/psychology. His passion is to help individuals who have experienced life in conflict-affected settings (e.g., Refugees, Veterans) build resilience and find healing. Philip is involved in multiple research projects such as MDMA-assisted group therapy for PTSD and psilocybin-enhanced psychotherapy for methamphetamine use disorder in Veterans. Broadly, Philip is interested in the role of epistemic trust, attachment security and spirituality/metaphysical beliefs in the context of psychedelic-assisted psychotherapy — including how any changes in these domains may relate to psychological well-being and psychopathology.
David Tay, MD | Psychiatric Resident
David (he/him) is a psychiatry resident at Oregon Health and Science University (OHSU). He serves as a study physician for SNaP Lab clinical trials and as a representative on the Inclusivity, Diversity, and Anti-racism (IDA) committee in the OHSU Department of Psychiatry. Originally from New York City, he first explored his interest in human thought and behavior through a performing arts career, including a role on Broadway. He broadened his understanding of psychology and multiculturalism through a bachelor’s degree at the University of Michigan with a focus in Marketing and Japanese, spending his summers studying and working in Tokyo. He learned intimately of mindfulness practices through his training as a Yoga Alliance-registered yoga teacher. He identifies as part of the LGBTQ+ community and has worked in LGBTQ+ political and mental health spaces, including as a suicide hotline counselor at the Trevor Lifeline/Project. As the grandson of two Holocaust survivors, he took an interest in PTSD and worked with Veterans of the Iraq and Afghanistan wars to discover biomarkers for PTSD via New York University and the Department of Defense. He is enthusiastic about the unique potential of psychedelics to facilitate healing and enjoys singing, hiking, and playing video games in his spare time.
Alex Molina, MD | Psychiatric Resident
Alejandro (he/him) is a first-generation Guatemalan-American who is completing his psychiatry residency training at Oregon Health & Sciences University. He currently serves as a study physician for SNaP Lab clinical trials. He previously worked as a Night Attendant at the MAPS Phase II/III MDMA-assisted Psychotherapy for PTSD clinical trial site in his hometown of New Orleans while completing medical school. He also served as a research assistant under Dr. Charles Nichols in the LSU Department of Pharmacology, investigating the anti-depressant properties of psilocybin and ketamine using animal behavioral models, as well their effects on a cellular level by measuring neuronal transcription factors in vitro. He completed the MAPS MDMA Therapy Training Program in 2021 and will be pursuing facilitator certification under the Oregon Psilocybin Services act in 2023. He is interested in drug-policy reform, developing best-practices for safely incorporating psychedelics into clinical psychiatry, the role of music in psychedelic therapy, and the cultural aspects of entheogen use across human history.
Jason Jarria, MD | Psychiatric Resident
Jason (he/him) is a psychiatry resident at the Oregon Health and Science University. He previously completed his undergraduate degree in economics at the University of Michigan in 2014 with summa cum laude distinction. Following his longstanding enthusiasm for science and business, he joined an analytical laboratory where he spearheaded marketing initiatives that grossed over $1 million in additional revenue. He transitioned to a career in healthcare and completed his medical degree at the University of Arizona in 2020. During medical training, he participated in quality improvement projects aimed at reducing ED recidivism and hospital readmissions at academic medical centers, contributed to textbook chapters on innovative medical technologies to support healthcare in developing countries, and published case reports on novel surgical techniques. In the realm of psychedelics, he is most enthusiastic about the role of psilocybin in treating mood and anxiety disorders. In his free time, he enjoys traveling, cooking, reading, and hiking.
Josiah Laughlin, RN | PMHNP student
Josiah (he/him) completed his undergraduate at the Oregon Health & Sciences University School of Nursing and is continuing on with the Psychiatric Mental Health Nurse Practitioner program. He currently is working in acute inpatient psychiatry. He is trained in MDMA-assisted therapy and is interested in psychedelic-assisted therapies as they pertain to treating and managing co-occurring disorders, such as substance use disorders and PTSD. Josiah identifies as in-recovery and has done so for over a decade now. He lives in Beaverton, OR with his wife and three dogs and enjoys travel, reading, dining out, running, jiu jitsu, and staying physically active.
Devon Holler |
Devon (he/him) is an Oregon Health & Sciences University medical student who is planning to specialize in Psychiatry. He is from Bend, Oregon and has a B.S. in Microbiology from Oregon State University. Prior to medical school, he worked as a research assistant in human microbiome and immunology wet labs. His primary interest in psychedelic medicine developed during his time as an EMT in a rural setting and a scribe in the Bend emergency room. Witnessing patients undergoing mental health crises inspired him to look beyond the current standards of care toward fields of innovative psychiatric therapies. He is passionate about the treatment of depression, addiction, and PTSD and is excited to have the opportunity to work in the field of psychedelic medicine with its great propensity for successfully treating those with these conditions.
Dominic Tapia | Medical student
Dominic (he/him) is an Oregon Health and Sciences University medical student. Dominic is exploring his interest in the fields of psychiatry and psychedelic medicine. While working with the SNaP Lab, he will be researching the relationship between psychedelic-assisted psychotherapy and delay discounting.